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Abstract
Inflammation is a recognized risk factor for the vulnerable atherosclerotic plaque.
USPIO-enhanced MRI imaging is a promising non-invasive method to identify high-risk
atheromatous plaque inflammation in vivo in humans, in which areas of focal signal loss on MR
images have been shown to correspond to the location of activated macrophages, typically at the
shoulder regions of the plaque. This is the first report in humans describing simultaneous USPIO
uptake within atheroma in two different arterial territories and again emphasises that
atherosclerosis is a truly systemic disease. With further work, USPIO-enhanced MR imaging may
be useful in identifying inflamed vulnerable atheromatous plaques in vivo, so refining patient
selection for intervention and allowing appropriate early aggressive pharmacotherapy to prevent
plaque rupture.
Background
It is accepted that vulnerable atheromatous plaque has a
thin fibrous cap and large lipid core with associated
inflammation [1]. This inflammation can be detected on
Magnetic Resonance (MR) imaging using Ultra Small
Super-Paramagnetic Iron Oxide (USPIO) particles as a
contrast medium (Sinerem™). This has been validated
against the histological gold standard in previous work
[2]. Ex-vivo imaging of atheroma allows an extended
imaging-time thereby permitting greater signal-to-noise
and improving plaque characterisation. This has been
shown to correlate well with in-vivo imaging.
Case Presentation
A 72-year old male was referred to the vascular outpatient
clinic with an asymptomatic right carotid bruit, for work
up before planned coronary artery bypass grafting. His
duplex ultrasound showed a 70–80% stenosis of the right
internal carotid artery. He was found also to have an inci-
dental 5.6 cm infra-renal abdominal aortic aneurysm
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(AAA). He underwent multi-sequence MR imaging pre-
and 36 hours post USPIO infusion. Multi spectral imaging
was acquired at 1.5 Tesla using a whole body system (GE
Medical Systems, Milwaukee) and a custom designed 4-
channel phased array neck coil (Flick Engineering Solu-
tions BV) along with a standard body coil to improve sig-
nal to noise ratio. The patient subsequently (24 hours)
underwent a right carotid endarterectomy and was dis-
charged home after an uncomplicated hospital stay of
three days.
T2* weighted spiral imaging of the right common carotid artery in-vivo, pre (A) and 36 hours post USPIO infusion (B) showing  signal loss in areas of USPIO uptake (yellow arrows) Figure 1
T2* weighted spiral imaging of the right common carotid artery in-vivo, pre (A) and 36 hours post USPIO infusion (B) showing 
signal loss in areas of USPIO uptake (yellow arrows). (The 2D T2* weighted spiral acquisition used a spectral-spatial excitation 
pulse, with a TE of 5.6 ms. The multi-shot spiral sequence involved the acquisition of 22 spiral interleafs each of 4096 data 
points resulting in an effective in-plane pixel size of 0.42 × 0.42 mm, two signal averages were performed and a quadruple 
inversion preparation was utilised to null the signal from blood pre – and post USPIO. Slices were acquired sequentially with a 
3 mm thickness and no inter-slice gap.). Pre (C) and 36 hours post USPIO infusion (F) T2* weighted spiral imaging in-vivo reveal-
ing signal drop in the wall of the aneurysm post-USPIO (yellow arrows) likely corresponding to regions with a high inflamma-
tory burden. Corresponding ex-vivo imaging in a dedicated micro-coil with T2 map (D) showing regions with very short T2 
species (yellow arrow) corresponding with area of USPIO uptake. Ex-vivo inversion recovery on-resonance water suppression 
(IRON) imaging [9] (E) with off-resonant spins showing positive contrast due to dephasing of spins adjacent to USPIO uptake. 
H&E section (x40) co-registered with ex-vivo imaging (using distance from the bifurcation). Area of intraplaque haemorrhage 
within a small necrotic lipid core can be seen (red arrow), adjacent to the USPIO uptake seen in the ex-vivo imaging. Structural 
MR Imaging in the same patient reveals anatomy of the co-existing abdominal aortic aneurysm (H&J).Annals of Surgical Innovation and Research 2007, 1:4 http://www.asir-journal.com/content/1/1/4
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The ex-vivo specimen was kept fresh and immersed in an
MR inert fluid (Fomblin, Performance Fluids Ltd, UK) and
imaged in a dedicated single channel micro-coil 4 hours
after surgery. Following this, the specimen was washed,
fixed in formalin and embedded in paraffin wax. The par-
affin block was divided into 3 mm sections and thin sec-
tions were cut from each block. These sections were
stained using various techniques including haematoxylin
and eosin (H&E) and elastin Van Giesen (EVG). This his-
tology was co-registered with the ex-vivo and in-vivo MR
using the bifurcation as a point of reference. There were
no problems with the co-registration of the in-vivo images
with the ex-vivo images or the histology (see Figure 1).
An elective endovascular repair of his AAA has been sched-
uled.
Conclusion
Treatment decisions for surgical intervention in patients
with asymptomatic carotid atheroma remain controver-
sial. Conventional clinical risk assessment of carotid
atheroma is based currently on luminal stenosis alone [3].
Although important, methods used to measure luminal
stenosis such as conventional x-ray angiography and CT
angiography do not adequately reflect disease severity in
carotid atherosclerosis. They do not permit assessment of
the morphology and inflammatory infiltrate of the lesion,
which are all recognised risk factors for the vulnerable
carotid atheromatous plaque [4]. Furthermore, the proc-
ess of expansive arterial remodelling [5] may produce nor-
mal luminal measurements despite a large atheromatous
plaque burden in a particular patient and therefore under-
estimate their risk of stroke.
USPIO-enhanced MRI imaging is a promising non-inva-
sive method to identify high-risk atheromatous plaque
inflammation in vivo in humans, in which areas of focal
signal loss on MR images have been shown to correspond
to accumulation of iron particles in ex vivo specimens
[2,6]. USPIO is thought to accumulate predominantly in
activated macrophages either at the shoulders or in the
necrotic lipid core of ruptured and rupture-prone human
atherosclerotic lesions and is considered to be a marker of
the degree of inflammation within the plaque [7,8].
This is to the authors' knowledge the first report in
humans describing simultaneous USPIO uptake within
atheroma in two different arterial territories and again
emphasises that atherosclerosis is a truly systemic disease.
With further work, USPIO-enhanced MR imaging may be
useful in identifying inflamed vulnerable atheromatous
plaques in vivo, so refining patient selection for interven-
tion and allowing appropriate early aggressive pharmaco-
therapy to prevent plaque rupture. It may also prove a
useful adjunct in the identification of inflammation
within other vascular beds such as in the detection of
inflammatory abdominal aortic aneurysms, which may
contribute to surgical decision making in the future.
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